Died (n = 45) | Survived (n = 55) | p value | |
---|---|---|---|
No (%) | No (%) | ||
Age in years, median (range) | 67 (0–88) | 62 (0–88) | - |
Gender, male | 23 (51.1) | 35 (63.6) | 0.29 |
Hematological malignancy | 3 (6.6) | 3 (5.4) | 0.31 |
Advanced cancer | 10 (22.2) | 8 (14.5) | 0.54 |
Diabetes mellitus | 16 (35.5) | 16 (29.1) | 0.22 |
Corticosteroid use | 4 (8.8) | 8 (14.5) | 0.31 |
Chemotherapy | 4 (8.8) | 11 (20) | 0.2 |
Neutropenia (<0.5 G/L) | 5 (11.1) | 2 (3.6) | 0.24 |
Post-transplantation stage | 0 | 5 (9.1) | - |
Chronic heart disease | 15 (33.3) | 18 (32.7) | 0.88 |
Chronic kidney disease, hemodialysis | 10 (22.2) | 5 (9.1) | 0.12 |
Chronic lung disease | 13 (28.8) | 14 (25.4) | 0.87 |
Chronic liver disease | 5 (11.1) | 7 (12.7) | 0.95 |
Hypertension | 30 (66.6) | 25 (45.4) | 0.05 |
Admission to intensive care unit | 43 (95.5) | 32 (58.2) | 0.00005 |
Need for vasopressors | 26 (57.7) | 8 (14.5) | 0.00001 |
Central venous catheter | 42 (93.3) | 29 (52.7) | 0.00001 |
Need for mechanical ventilation | 41 (91.1) | 28 (50.9) | 0.00004 |
Severe sepsis, septic shock, multiorgan failure | 23 (51.1) | 5 (9.1) | 0.00001 |
Non-S. maltophilia bloodstream infection | 15 (33.3) | 9 (16.3) | 0.08 |
S. maltophilia bloodstream infection | 12 (26.6) | 13 (23.6) | 0.9 |
Recent surgery | 18 (40) | 12 (21.8) | 0.08 |
Polymicrobial infection | 35 (77.7) | 33 (60) | 0.09 |